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Abstract: The genome of Penicillium chrysogenum Q176 contains a gene coding for the 
88-amino-acid (aa)-long glycine- and cysteine-rich P. chrysogenum antifungal protein C (PAFC). 
After maturation, the secreted antifungal miniprotein (MP) comprises 64 aa and shares 80% aa 
identity with the bubble protein (BP) from Penicillium brevicompactum, which has a published X-ray 
structure. Our team expressed isotope (15N, 13C)-labeled, recombinant PAFC in high yields, which 
allowed us to determine the solution structure and molecular dynamics by nuclear magnetic res-
onance (NMR) experiments. The primary structure of PAFC is dominated by 14 glycines, and 
therefore, whether the four disulfide bonds can stabilize the fold is challenging. Indeed, unlike the 
few published solution structures of other antifungal MPs from filamentous ascomycetes, the NMR 
data indicate that PAFC has shorter secondary structure elements and lacks the typical β-barrel 
structure, though it has a positively charged cavity and a hydrophobic core around the disulfide 
bonds. Some parts within the two putative γ-core motifs exhibited enhanced dynamics according 
to a new disorder index presentation of 15N-NMR relaxation data. Furthermore, we also provided a 
more detailed insight into the antifungal spectrum of PAFC, with specific emphasis on fungal plant 
pathogens. Our results suggest that PAFC could be an effective candidate for the development of 
new antifungal strategies in agriculture. 
Keywords: Penicillium chrysogenum; antifungal protein PAFC; γ-core motif; solution structure; 
dynamics; nuclear magnetic resonance; plant protection 
 
1. Introduction 
Fungal infections of humans, animals, and plants have a severe impact on global 
health and jeopardize the food supply and wildlife biodiversity [1]. A major challenge in 
combating fungal diseases is the limited number of targets for effective antifungal ther-
apy that is tolerated by the host. Therefore, the development of antifungal drug re-
sistance poses a dangerous and fast-evolving risk, which strongly demands the search for 
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new antifungal compounds with novel mechanisms of action and fungal-specific unique 
targets. Very promising candidates [2–5] for new antifungal strategies are represented by 
small, cysteine-rich, and cationic proteins from diverse organisms [6]. Filamentous as-
comycetes are a rich source of secreted miniproteins (MPs) that exhibit high and exclu-
sive efficacy against the growth of human, animal, and plant pathogenic fungi [7–9], and 
the first evidence promises antiviral efficacy as well [10]. These small and positively 
charged MPs have disulfide-stabilized β-barrel folds that render them tolerant toward 
high ion concentrations, extreme temperature, and proteolytic degradation [8–14]. Since 
no cytotoxic effects in mammalian cells have been described in vitro and in vivo so far 
[9,11–13], they are considered promising candidates for alternative antifungal strategies 
in clinics, veterinary science, agriculture, and food production. 
Penicillium chrysogenum is unique among filamentous ascomycetes as its genome 
contains three genes coding for cysteine-rich, cationic MPs with reported antifungal ac-
tivity: the P. chrysogenum antifungal protein (PAF), P. chrysogenum antifungal protein B 
(PAFB), and P. chrysogenum antifungal protein C (PAFC) [9,14]. It is known that P. 
chrysogenum MPs enter sensitive fungal cells without disrupting the plasma membrane, 
but they accumulate in the cytoplasm, induce the generation of intracellular reactive 
oxygen species (ROS), and ultimately trigger cell death [9,10,14,15]. The extensively 
studied PAF has a complex antifungal mode of action that is linked to cell signaling in-
volving heterotrimeric G-protein [16] and protein kinase A [17], cation channels [18,19], 
and glucosylceramide synthesis [20] and is regulated by a specific protein motif that 
structurally resembles the Greek letter gamma (γ) [21]. This common, so-called γ-core 
motif with the consensus sequence GXCX3-9C (dextromeric form) or 
CX3-9CXGX1-3/CX3-9GXCX1-3 (levomeric forms) is found in many cysteine-stabilized MPs 
originating from organisms of diverse kingdoms [22,23]. 
The mature PAFC [14] is a unique example of antifungal MPs, since it has a molec-
ular mass of 6.63 kDa and is slightly longer (64 amino acids (aa)) than the mature PAF (55 
aa; 6.25 kDa) and PAFB (58 aa; 6.55 kDa) [10,11]. It shows 80% aa identity with the bubble 
protein (BP) of Penicillium brevicompactum [24] and 83% identity with the Penicillium ex-
pansum antifungal protein C (PeAfpC) [25] (Figure 1). Therefore, it phylogenetically be-
longs to the BP-clade of ascomycetous MPs, which is distinct from the PAF-clade that 
comprises the PAFC-related MPs PAF and PAFB [21]. PAFC contains an unusually high 
number of glycines (14) and has a net charge of +3.6 ± 0.1 at pH 4.5, as calculated consid-
ering the disulfide bonds, using in-house-written MATLAB code. This is due to a smaller 
number of cationic residues (6 arginines, 2 lysines, and 1 histidine) compared to PAF (13 
lysines; net charge +6.7 ± 0.1; pH 4.5) and PAFB (8 lysines, 2 arginines, and 4 histidines; 
net charge +11.5 ± 0.2; pH 4.5). Furthermore, PAFC has two putative levomeric γ-core 
motifs (CX3-9CXGX1-3). One of them—positioned in the center of PAFC (CDRT-
GIVECKG)—is highly conserved among the MPs of the BP-clade, while the second, 
shorter one with lower homology resides near the C-terminus (CGGASCRG) (Figure 1) 
[14]. 
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Figure 1. ClustalW multiple alignment of the mature, P. brevicompactum “bubble protein” BP-clade-specific MPs of Eu-
rotiomycetes [21]. P. chrysogenum PAFC (Pench_146100) is framed in blue. The two conserved γ-core motifs found in the 
members of this clade are framed in red. The abbreviations of the full species names and the protein accession number are 
indicated: Penbr (P. brevicompactum), Pench (P. chrysogenum), Penfla (Penicillium falvigenum) Penla (Penicillium lanoso-
coeruleum), Penpol (Penicillium polonicum), Pencop (Penicillium coprophilum), Penswi (Penicillium swiecickii), Penex (Penicillium 
expansum), Penvul (Penicillium vulpinum), Asptaic (Aspergillus taichungensis), Aspcand (Aspergillus candidus), Asptr (Asper-
gillus triticus), Aspcam (Aspergillus campestris), Aspeamy (Aspergillus amylovorus), Aspve (Aspergillus versicolor), Neofi (Ne-
osartorya fischeri), Aspnov (Aspergillus novofumigatus), Penant (Penicillium antarticum), and Aspbom (Aspergillus bombycis). 
The color coding of aa was applied according to ClustalX. The conservation between the respective sequences based on 
the ClustalW2 Multiple Sequence Alignment tool [26] is indicated at the bottom. 
In previous studies, we acquired nuclear magnetic resonance (NMR) structure data 
of MPs of the filamentous ascomycetes Penicillium chrysogenum (PAF, 2mhv) [19,27], short 
form of PAFB, (sfPAFB, 2nc2) [9,10], and Neosartorya fischeri antifungal protein (NFAP, 
5oqs) [28–30] that support a better understanding of the protein function and foster the 
improvement in antifungal efficacy by intentional modifications (protein engineering) 
[21]. 
So far, information about the three-dimensional structural data of MPs of the 
BP-clade is limited, as an X-ray structure was published only for the P. brevicompactum BP 
[24] and an in silico structure prediction exists for PAFC [14]. As the aa sequence of PAFC 
shows special features, our emphasis in this study was to experimentally verify that this 
MP has a folded structure, since the glycine-rich sequence requires four disulfide bonds 
to achieve folding. By acquiring the solution structure of PAFC, we disclosed its struc-
tural similarity to and differences from other antifungal MPs from ascomycetes. An 
overall low positive net charge, a short helix besides the five β-strands, and a positively 
charged cavity distinguish PAFC from the other two P. chrysogenum antifungal proteins 
PAF and PAFB. NMR relaxation-based dynamics was used to verify the monomeric and 
mostly rigid structure of PAFC. Dynamical peculiarities of the γ-core motif are important 
observations, since these regions are reported to contribute to the antimicrobial impact 
and spectrum of defensins and cationic MPs [22]. Finally, we provide an extended insight 
into the antimicrobial potential of PAFC and prove its specific antifungal but not anti-
bacterial efficacy. As a proof-of-principle, we show the applicability of PAFC as a 
bio-fungicide in agriculture, as it protects tomato plant leaves against infection by the 
necrotrophic plant pathogen Botrytis cinerea. 
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2. Results 
2.1. Characterization of Structural and Dynamical Properties of PAFC 
Solution NMR spectroscopy was employed with the 15N- and 13C-labeled recombi-
nant PAFC. All amide backbone and side-chain groups could be identified and assigned 
in the 1H-15N heteronuclear single quantum correlation (HSQC) spectrum due to the high 
dispersion of amide (NH) signals (Supplementary Figure S1). This fingerprint clearly 
showed that the protein adopts a well-folded structure. Many NH signals are split by 
high 3J (HN, HA) couplings, typical for β-strands. The large majority (97.1%, 90.6%, and 
85.1%) of the 15N, 13C (all carbons, without aromatics), and 1H chemical shifts were suc-
cessfully assigned. More than the half of the nuclear Overhauser effects (NOEs) proved to 
be either medium- (12.0%) or long-range (43.9%) interactions, which indicated a 
β-structure for PAFC. The Cβ 13C chemical shift values of all cysteines were typical for 
disulfide bridges [31], as expected. PAFC has the same abcabdcd-type disulfide bond 
pattern as BP, connecting 3-30, 18-38, 28-54, and 49-64 cysteines. This assumption was 
firmly supported by the structure calculations. When no disulfide bond constraints were 
added to the NOE constraints, nearly identical structures were obtained as with the di-
sulfide-constrained cases. The high number of distance (14.3 NOE/residue) and backbone 
torsional angle constraints allowed us to calculate a high-quality NMR structure with a 
low (0.55  0.06 Å) heavy-atom root-mean-square deviation (RMSD) value in the final 
model. The three-dimensional structure and chemical shift assignments of PAFC were 
deposited to the Protein Data Bank (pdb code 6TRM) and the Biological Magnetic Reso-
nance Data Bank (BMRB entry no. 34468), respectively. According to official pdb valida-
tion analysis, only Cys3 was an outlier for Ramachandran statistics (Supplementary Ta-
ble S1) of backbone dihedral angles, and according to our records no NOE violations 
were found. 
The three-dimensional structure of PAFC (Figure 2A) shows the characteristic fold 
of the BP-clade as aligned with BP (Figure 2B), with an RMSD deviation of 1.01 Å be-
tween the two structures. The N-terminal part of the protein (1–25) does not form strict 
secondary structure elements. Though the random coil index (RCI) [32] derived from 
NMR chemical shifts was well below the critical 0.2 value, a peak value of 0.15 close to 
the N-terminus (around Gly8) is a sign of disorder. Also, according to the lower number 
of NOEs at the N-terminus, the conformations of the first seven residues are less 
well-defined if compared to the rest of PAFC. The next region (aa 8–19) adopts a mostly 
extended structure, interrupted by bend and turn-like motives (aa 9–10, aa 14–15). It is 
followed by a short and irregular 310-helix (Ala20–Asp24). In contrast, the C-terminal part 
of the protein forms a β-strand structure with two antiparallel β-sheets. The first one 
consists of three (β1, β2, and β3) and the latter one of two (β4, β5) β-strands. The posi-
tions of strands are His26–Cys28 for β1, Gly34–Lys39 for β2, Lys42–Asp48 for β3, Arg55–
Val57 for β4, and Gly60–Arg63 for β5. The first, longer β-sheet is somewhat right-handed 
twisted, similarly to that of BP. Although the second one proved to be more irregular, still 
all the possible H-bonds were experimentally identified in this region (Table 1). 
Int. J. Mol. Sci. 2021, 22, 1183 5 of 23 
 
 
 
Figure 2. Comparison of the structures of Penicillium spp. MPs. (A) The NMR solution structure of the PAFC (pdb code 
6TRM). The position of the Cys residues is indicated, and the disulfide bonds are labeled as yellow sticks. (B) Superim-
posed structures of the PAFC (pdb code 6TRM) and the P. brevicompactum BP (gray color; pdb code: 1UOY) using Chi-
mera visualization software [33]. (C) Backbone NMR conformational ensemble of 20 structures of PAFC. 
Table 1. Observed long-range hydrogen bonds in PAFC, identified in the hncogphb3d NMR spectrum [34]. 
Secondary Structure Elements Residue with Amide Hydrogen Residue with Carbonyl Oxygen 
β1-β2 29Gly 34Gly 
β1-β2 36Val 27Phe 
β1-β2 27Phe 36Val 
β2-β3 35Ile 47Gln 
β2-β3 37Glu 44Thr 
β2-β3 39Lys 42Lys 
β2-β3 44Thr 37Glu 
β2-β3 46Ile 35Ile 
β2-β3 49Cys 33Thr 
β4-β5 55Arg 63Arg 
β4-β5 57Val 60Gly 
β4-β5 63Arg 55Arg 
N-terminal-β1 12Arg 28Cys 
N-terminal-β1 28Cys 10Asp 
N-terminal-β3 15Asn 43Trp 
N-terminal-β3 43Trp 16Ser 
loop1-β4 54Cys 32Arg 
N-terminal region 13Arg 1Asp 
More detailed examination of the β-strands revealed the amphipathic nature of β1, 
β2-, β4-, and β5-strands. Interestingly, both C-terminal strands are partially positively 
charged, and they do not contain any acidic residues. In contrast, β3 consists of several 
charged aa, and it is rather hydrophilic based on the aa sequence, especially compared to 
other parts of the protein. The fractional associated solvent area (fASA) parameters, as 
obtained from 13C chemical shifts [35], report on the buried parts of the structure (Figure 
3). Low fASA values are characteristic for buried residues. In PAFC, most minima are 
centered around the cysteines, thereby proving the existence of the usual disul-
fide-protected hydrophobic inner core of antifungal MPs [10,30]. 
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Figure 3. fASA values of PAFC calculated from 13C chemical shift data show residue-by-residue 
hydrophobicity of the structure. Residues with fASA values below 0.25 are considered strongly 
buried, while fASA values above 0.75 indicate exposure to solvent. 
Four small loops are situated between the β-strands. Three of them form β-turns 
(Cys30–Asp31, Gly40–Gly41, Ser58–Gln59), and the fourth, located between the two 
sheets, shows irregular γ-turn motives (at Gly50 and Ala52). The secondary structural 
analysis described above is consistent with that based on the Dictionary of Secondary 
Structures of Protein (DSSP) method [36]. PAFC, as a member of the BP-clade proteins, 
contains four disulfide bridges. While the first two (3–30, 18–38) connect the N-terminal 
region to the first β-pleated sheet, the others (28–54, 49–64) are located between the two 
sheets. This arrangement strongly stabilizes the tertiary structure of the protein, and this 
stability is further supported by several H-bonds formed between the N-terminal ex-
tended part and the β-sheets in the order of NH donor and CO acceptor sites (12Arg–
28Cys, 28Cys–10Asp, 15Asn–43Trp, and 43Trp–16Ser). In PAFC, the side chains of 
Asp31, Glu45, and Asp48 are close to each other and form a small negatively charged 
surface region with the hydrophilic residues Thr33 and Ser53. Interestingly, the most 
basic side chains face outside and do not interact with one another or any acidic residues. 
One possible salt bridge can be identified between the side chains of Glu37 and His26, 
and only two basic arginines (32 and 55) are close to each other. Though the aromatic side 
chains Trp43 and Phe27 interact with each other to some extent, no significant aromatic 
core is present in PAFC and only Arg12 is in their vicinity. In contrast, a small hydro-
phobic core with Ile35 in the center is found near the C-terminal disulfide bonds, in 
agreement with low fASA values.  
For studying the dynamical behavior of PAFC, 15N (70.96 MHz) NMR relaxation (T1, 
T2, NOE) measurements [37] were performed and evaluated using the Lipari–Szabo 
model-free method [38]. The 3.14 ± 0.36 ns global correlation time (τc) is similar to other 
monomeric antifungal MPs (PAF, NFAP). Details of relaxation analysis are provided in 
Table S2. The average S2 order parameter was calculated as S2 = 0.76 ± 0.11, which shows 
that PAFC has slightly higher flexibility on the ps–ns timescale if compared to PAF or 
NFAP [19,30]. To some surprise, the S2 values of even the N-terminal region proved to be 
similar to those of the β-strands (Supplementary Figure S2). Nevertheless, some residues 
are somewhat less rigid, including Gly6, Asn15, Glu37, Gly41, Gln47, Gly60, Gly61, and, 
especially, Gly51 and Ala52. Analysis of the R1*R2 relaxation rate combinations [39] 
showed that Arg32 and possibly Gly51 must be affected by chemical exchange (Supple-
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mentary Figure S3). The conventional reduced spectral density mapping approach 
(RSDM) [40] also suggests enhanced motions around Arg32 and Gly51 and to a lesser 
extent at Gly6, Tyr7, Gly8, Gly23, Thr33, Gly34, and E45 (Figure 4). Thus, the end of the 
first loop plus the β2-strand and the third loop are somewhat more flexible with higher 
mobility on the ps–ns timescale. However, Carr-Purcell-Meiboom-Gill relaxation disper-
sion (CPMG-RD) experiments could not detect mobility on a much slower (μs–ms) 
timescale (data not shown). 
 
Figure 4. Reduced spectral density mapping of NH mobilities in PAFC (298 K). The limiting con-
tinuous curve represents the absence of internal motion, as calculated by τc = 3.14 ns global corre-
lation time. Spectral densities (the strength of fluctuating radiofrequency fields from molecular 
rotational diffusion) at 15N frequency shown as a function of such fields close to zero frequency 
(slow-motion regime) [40]. JomN on the vertical axis shows the spectral densities at 15N frequency, 
while J0 on the horizontal axis is proportional to spectral densities close to zero frequency. The 
units of the two axes should be understood as 10−9 (s rad−1). 
For better visualization of the same 15N relaxation data, we introduced a so-called 
disorder index, where the geometric distance from the rigid-body limiting curve of Fig-
ure 4 is displayed as a function of the residue number. Figure 5 clearly shows that ex-
treme dynamics appears in the two γ-core regions between residues 30–40 and 49–56. 
Finally, we compared the RSDM, R1*R2 , and model-free (MF) methods. Using the first 
two methods, we found that slow exchange must persist in region 32–34, which is not 
reflected in MF S2 values. On the other hand, the S2 values are low at Gly51 (0.39) and 
Ala52 (0.58), suggesting enhanced dynamics here at the ps–ns timescale. This fast time-
scale dynamics was not sensed by the R1*R2 method. In contrast, the more general RSDM 
methods displayed enhanced dynamics in both regions, independent of the timescale. 
Interestingly, 15N CPMG-RD T2 relaxation dispersion experiments were insensitive in 
detecting dynamics at intermediate timescales (μs–ms range). 
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Figure 5. Disorder index (DI), as obtained directly from reduced spectral density mapping of 15N 
NMR relaxation data. The DI is just derived from Figure 4 by calculating the geometrical (shortest) 
distances of the points from the solid (limiting) curve. The γ-core regions are labeled as red bars, 
while other residues are blue. 
2.2. Secondary Structure and Thermal Stability Analysis of PAFC Using Electronic Circular 
Dichroism Spectroscopy 
The electronic circular dichroism (ECD) spectrum of PAFC at 25 °C showed mark-
edly different features to those observed previously for the related proteins (Figure 6A) 
PAF [41], PdAfpB from Penicillium digitatum [42], and NFAP and NFAP2 from Neosar-
torya fischeri [43,44]. The spectrum was characterized by a broad, intensive minimum at 
202 nm, which could indicate the presence of multiple structural elements with the pre-
dominance of atypical, non-canonical secondary structures. A contribution from a very 
low intensity maximum, centering around 229 nm, was revealed by comparison to the 
spectrum acquired at 95 °C. This low-intensity maximum indicated the presence of di-
sulfide bridges with uniform geometries. This suggested, in accordance with the results 
provided by NMR spectroscopic analysis, that the predominance of highly dynamic 
disordered structures could be ruled out and that the protein adopts a stable tertiary 
structure in aqueous solution. Monitoring the change of spectral intensity at 229 nm at 
elevated temperatures yielded an inverse sigmoid-type unfolding curve (Figure 6B), 
similar to those acquired previously for other cysteine-rich, cationic, antifungal MPs [41–
44]. Fitting the data points with an inverse sigmoid function (R2 = 0.936) appointed x = 
76.83653 as the inflection point of the fitted curve. Therefore, the melting point of the 
protein structure (Tm) could be estimated to be approx. 77 °C. This indicates remarkable 
thermal stability, similar to that of related proteins. The spectrum measured again at 25 
°C after heat treatment (Figure 6A) confirmed that the unfolding of PAFC is entirely re-
versible and corroborates the preservation of anti-Candida activity after heat treatment, as 
reported recently [14]. 
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Figure 6. ECD spectra and thermal unfolding curve of PAFC. (A) Spectra in the 185–260 nm region were measured at 25 
°C (green), 95 °C (red), and again 25 °C (blue) after refolding. (B) Thermal unfolding of PAFC, followed by ECD spectra at 
229 nm. Tm = 77 °C. 
Spectral deconvolution data and the estimation of secondary structural components 
are included in Table 2. While the contributions of helical and unordered segments are 
slightly overestimated by ECD spectra at the expense of β-strands and turn structures, 
there is an acceptable agreement between ECD and NMR data, especially when consid-
ering the limited site specificity of the former. 
Table 2. Estimation of secondary structural components of PAFC from ECD spectra compared to those obtained from 
NMR measurements. 
Secondary Structural 
Elements/% 
PAFC 
25 °C 
PAFC 
95 °C 
PAFC 
25 °C 
after Heating 
BP Crystallographic 
Structure (1UOY) § 
PAFC Solution NMR 
Structure (6TRM) § 
α- or 310-helix 13 15 14 5 6 
β-strand, extended 28 26 28 39 38 
β- or γ-turns, bends 26 26 25 31 33 
unordered 33 34 32 25 23 
§ The fraction of secondary structural elements was determined by DSSP analysis [36] of the NMR-derived PAFC struc-
ture and the crystallographic structure of the homologous P. brevicompactum BP [24]. 
2.3. Microbial Growth Inhibitory Activity of PAFC 
Recombinant, unlabeled PAFC was tested for antimicrobial activity, and the inhibi-
tory concentration that reduces growth by ≥90% (IC90) was determined (Table 3). The 
microorganisms tested in broth microdilution assays comprised Gram-positive (Bacillus 
subtilis) and Gram-negative (Escherichia coli) bacteria and filamentous fungi (the PAFC 
producer P. chrysogenum, the model organisms Aspergillus nidulans, Aspergillus niger and 
Neurospora crassa, the opportunistic human pathogen Aspergillus fumigatus, and the der-
matophytes Microsporum gypseum and Trichophyton rubrum). Filamentous fungi showed 
high tolerance (A. nidulans) or resistance (P. chrysogenum, A. fumigatus, and A. niger) to 
PAFC in the tested concentration range. Interestingly, Microsporum gypseum and Tri-
chophyton rubrum proved to be the most sensitive ones (IC90 5–7 μM). No growth inhibi-
tory activity was observed for bacteria at concentrations tested up to 50 μM. 
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Table 3. PAFC inhibitory concentrations that reduce the growth of microorganisms by ≥90% (IC90) 
$. 
Microorganism 
IC90 
µM µg mL−1 
Aspergillus fumigatus >30 199 
Aspergillus nidulans 30 199 
Aspergillus niger >30 199 
Neurospora crassa 15 99 
Penicillium chrysogenum 50 331 
Microsporum gypseum 7 46 
Trichophyton rubrum 5 33 
Bacillus subtilis >50 331 
Escherichia coli >50 331 
$ Broth microdilution assays were performed to determine the IC90. Microorganisms were grown in 
ten-fold-diluted potato dextrose broth (0.1 × PDB) for 24 h at 30 °C in static culture before meas-
urement of the optical density at wavelength 620 nm (OD620nm). Exceptions: N. crassa was grown for 
16–30 h at 25 °C, and M. gypseum and T. rubrum were grown for eight days at 30 °C. IC90 was de-
fined as the PAFC concentration that inhibited growth by ≥90% compared to the untreated control, 
which represented 100% growth. 
2.4. The Role of the γ-Core Motif in the Antifungal Activity of PAFC 
In a previous study, we showed that the peptide spanning the dextromeric γ-core 
motif of PAF effectively inhibits fungal growth by its own and the efficacy can be in-
creased by modulating its physicochemical properties, i.e., increase in the positive net 
charge and hydrophilicity [21]. To assess the importance of the two levomeric γ-core 
motifs for PAFC activity, two peptides spanning the highly conserved motif (CDRT-
GIVECKG) residing in the protein center and one peptide covering the γ-core 
(CGGASCRG) at the protein C-terminus were chemically synthesized. The 15-aa-length 
peptide PCγ15 (FCGCDRTGIVECKGG) comprised the additional residues Phe-Cys-Gly 
at its N-terminus and showed an almost neutral net charge (−0.2 at pH 7) and a higher 
grand average of hydropathy (GRAVY) value (−0.087) than the full-length protein 
(charge +0.6 at pH 7, GRAVY −0.767) (Table 4). PCγ17, a 17-aa-long peptide 
(RHFCGCDRTGIVECKGG) included the two additional basic residues Arg and His at its 
N-terminus. It therefore exhibited a higher positive net charge (+1.1 at pH 7) than PAFC 
and PCγ15 and a GRAVY value of −0.376, rendering this peptide more hydrophilic than 
PCγ15. Lastly, to determine the role of the putative C-terminal γ-core, the 8-aa-long 
peptide PCγC-terminal (CGGASCRG) was synthesized, having a similar positive net charge 
as PAFC (+0.8 at pH 7) but showing the highest GRAVY value of +0.038 (Figure 7 and 
Table 4). 
 
Figure 7. The primary structure of PAFC and the derived synthetic γ-core peptides. The aa sequence of PAFC is indicated 
by a one-letter code. The predicted levomeric γ-core motifs in the center and the C-terminus are highlighted in red. Be-
low, sequences of the N-terminally acetylated (Ac-) synthetic peptides PCγ15, PCγ17, and PCγC-terminal are indicated. 
Determination of the antifungal potential of the peptides was performed by testing 
their growth inhibitory activity on the human pathogenic yeast Candida albicans and the 
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filamentous model fungus N. crassa up to concentrations of 100 μM. Interestingly, Pγ15 
and PCγC-terminal did not inhibit fungal growth in the tested concentration range. PCγ17, 
however, was effective against N. crassa at an IC90 of 25 μM but not against C. albicans, 
which is sensitive to the full-length PAFC, as recently reported [14]. The positive net 
charge and hydrophobicity are important determinants of the antifungal potential of 
γ-core peptides and their analogues [9,21,44–46]. Our data indicated that the predicted 
canonical PAFC γ-core motives are not functional per se as long as the positive charge is 
low and the GRAVY value high. The increase in the net charge and the hydrophilicity of 
the peptide enhance the species-specific antifungal activity. However, the efficacy is still 
ten-fold lower than that of the full-length protein. This let us conclude that other protein 
parts are necessary to execute to full antifungal activity. 
Table 4. Physicochemical characteristics and the fungal growth inhibitory potential (IC90) of the 
peptides PCγ15, PCγ17, and PCγC-terminal compared to the full-length MP PAFC §. 
Protein/Peptide 
Molecular 
mass (kDa) 
Charge  
(pH 7.0) 
GRAVY 
IC90  
N. crassa C. albicans 
µM µg mL−1 µM µg mL−1 
PAFC 6.6 +0.6 −0.767 12.5 83 2.5 17 
PC 15 1.5 −0.2 +0.087 >100 66 >100 66 
PC 17 1.8 +1.1 −0.367 25 166 >100 66 
PC C-terminal 0.7 +0.8 +0.038 >100 66 >100 66 
§ The calculated molecular mass (kDa, ExPasy ProtParam tool), the predicted net charge (at pH 7, 
http://protcalc.sourceforge.net), and the GRAVY value (www.gravy-calculator.de) are indicated. 
For determination of IC90 values in 0.1 × PDB, C. albicans was grown for 24 h at 30 °C and N. crassa 
for 16–30 h at 25 °C. IC90 was defined as a protein/peptide concentration that inhibited growth by 
≥90% compared to the untreated control, which represented 100% growth. 
2.5. Effect of PAFC on Medicago truncatula Seedlings 
Recently, we reported on the efficacy of PAFC to inhibit the growth of one of the 
most prevalent human pathogens, the yeast C. albicans, which renders this MP a prom-
ising candidate for the development of new drugs for the treatment of skin and cutane-
ous fungal infections [14]. In this study, we provide a proof-of-principle that PAFC also 
protects plants from fungal infection. To consider this MP as a biocontrol agent in agri-
culture, it is of utmost importance to first exclude any harmful effect on the growth and 
development of plants. The small and fast-growing legume Medicago truncatula is an ap-
propriate model plant to study the harmful effects of pesticides and antifungal com-
pounds like MPs [47]. Thus, M. truncatula A-17 seedlings grown on water agar in Petri 
dishes were daily treated with 1 mg mL−1 of PAFC to evaluate the primary root length 
and the number of lateral roots. No harmful effects were detected after 10 days of incu-
bation between the PAFC-exposed samples compared to the ddH2O-treated negative 
control, whereas significant changes in the root morphology were observed with the 
positive control, which was daily treated with 70% (v/v) ethanol (Figure 8). 
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Figure 8. Vegetative growth and root development of Medicago truncatula A-17. (A) Morphology of plant seedlings and 
(B) primary root length (gray bars) and number of lateral roots (hatched bars) after daily treatment with 1 mg mL−1 of 
PAFC for 10 days at 25 °C under continuous illumination (1200 lux) compared to the ddH2O- and 70% (v/v) etha-
nol-treated controls, respectively. Scale bar, 30 mm. Significant difference in (B) was evaluated with the two-sample t-test 
and is indicated with ** (p < 0.005). 
2.6. Protection of Tomato Plant Leaves from Botrytis cinerea Infection 
To prove that PAFC can protect plants from fungal infection, we applied a test sys-
tem that uses the necrotrophic surface plant pathogen Botrytis cinerea that infects tomato 
plant leaves. To approximate more natural conditions, we used the agar diffusion assay 
instead of the broth microdilution assay to investigate the antifungal potential of PAFC 
on this filamentous plant pathogen growing on solid surfaces. PAFC was applied into the 
wells of agar plates in a concentration range of 37–151 μM (0.25–1 mg mL−1). The deter-
mination of the diameters of the inhibition zones around the wells correlated with the 
PAFC concentration, whereas no growth inhibition could be detected around the ddH2O 
control well (Table 5). 
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Table 5. Inhibition of Botrytis cinerea surface culture growth by PAFC §. 
PAFC (mg mL−1) Diameter of Inhibition Zone (mm) 
0.25 16.5 ± 0.71 
0.5 17.0 ± 0.00 
0.75 18.5 ± 0.71 
1.0 20.0 ± 0.00 
§ Botrytis cinerea SZMC 21,472 was grown on 0.1 × PDA plates for 96 h at 25 °C. 
Microscopy revealed disintegrated conidia and a very low number of germlings in 
the inhibitory zone around the wells in which 1 mg mL−1 of PAFC had been applied, 
while healthy, well-developed hyphae were found around the control well containing 
ddH2O (Supplementary Figure S4). 
Next, we infected tomato plant leaves by applying B. cinerea spores alone (infection 
control) or together with 1 mg mL−1 of PAFC onto the abaxial leaf epidermis at three 
points per leaf between the lateral veins and analyzed necrosis development around the 
application sites after four days of incubation (Figure 9). Leaves similarly treated with 
PAFC alone (PAFC toxicity control), treated with 0.1 × PDB (medium toxicity control), or 
left untreated served as negative controls. Evan’s blue staining was performed to detect 
necrotic zones and revealed no tissue damage in any of the controls (Figure 9A,B), cor-
roborating the tolerance of PAFC by tomato plant leaves. Instead, considerable necrotic 
tissue around the side of B. cinerea application became visible in the infection control 
(Figure 9C, left side). The presence of PAFC in the infective inoculum, however, signifi-
cantly reduced necrotic areas on the leaves (Figure 9C, right side). These data clearly in-
dicated that PAFC effectively inhibits B. cinerea growth on the plant leaf surface. 
 
Figure 9. PAFC tolerance of tomato plant leaves and protective effect of PAFC against B. cinerea infection. The phenotype 
of leaves is shown in the left panels and damage evaluation with Evan’s blue staining in the right panels. (A) Leaves were 
either left untreated or treated with 10 μL of 0.1 × PDB (negative controls). (B) For toxicity testing, leaves were treated 
with 10 μL of PAFC (1 mg mL−1). (C) Plant protection efficacy was evaluated with leaves infected with 10 μL of B. cinerea 
conidia (107 conidia mL−1) (infection control) and conidia mixed with PAFC (1 mg mL−1). Plants were then further incu-
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bated for four days at 23 °C under photoperiodic day/night simulation (12/12 h with or without illumination at 1200 lux) 
and then harvested for staining. Scale bar, 10 mm. 
3. Discussion 
To unravel the PAFC solution structure at the atomic level, a detailed NMR study 
was undertaken. The PAFC protein belongs to the BP-clade of ascomycetous MPs. The 
three-dimensional structure of only one member thereof, the BP from P. brevicompactum, 
was determined using X-ray crystallography [24]. For PAFC, homology-based in silico 
structure prediction was performed earlier [14], which suggested the same fold (RMSD = 
0.46 Å) as BP. Therefore, only the two experimental atomic-level structures were com-
pared here. Since PAFC and BP have high sequence identity (80%), it is not surprising 
that their folds are very similar. They form a long N-terminal region with mostly ex-
tended and a short helix-like conformation and two antiparallel β-pleated sheet systems 
at the C-terminus. In both cases, four disulfide bridges are formed with the same 
abcabdcd pattern. In fact, the two proteins resemble each other so much that the back-
bone RMSD is only 1.01 Å. The main difference between them is that the N-terminus 
between residues 1–7 is slightly less ordered in PAFC than in BP. The same is true for the 
C-terminal β-sheet, which is shorter and more irregular in PAFC. Similar to BP, there is a 
hole in PAFC, which we call cavity A (Supplementary Figure S5), which seems to be a 
characteristic feature of the members of the BP-clade [24]. The outer margin of this funnel 
consists of several positively charged residues (Arg12, Arg13, and Arg25), which confer 
this part an overall basic nature. However, the side chains of these aa do not interact with 
each other, and no strong positively charged patch is present in the protein. The inner 
base of the funnel is formed by the aromatic Phe27 and Trp43 and in part by the charged 
Arg12. It is important to note that the cavity A structure is similar to that found in BP and 
it is formed by highly conserved residues [24]. This suggests that it may play an im-
portant functional role for BP-clade proteins. Interestingly, a second hole (cavity B, Fig-
ure 10B) can also be observed in PAFC. It is more hydrophilic and predominantly formed 
by the negatively charged Asp31, Glu45, and Asp48 as well as the basic Arg12 main 
chain, Arg13 and Arg32, and the hydrophilic residues Thr14, Thr33, and Thr44. The 
negatively charged region identified in BP was searched also in PAFC. Although it exists 
in PAFC as well, it is smaller there (Asp31, Asp48, and Glu45) and does not include the 
C-terminal region [14]. The electrostatic surface potential of PAFC is shown in Figure 
10A, as calculated from the pdb-deposited 6TRM structure. 
 
Figure 10. (A) Electrostatic potential surface of PAFC, as calculated [48] from the 6TRM structure 
deposited in pdb. Red means negative, and blue means positive surfaces. The scale is in kJ/mol/e. 
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(B) Front view of cavity B of PAFC, formed predominantly by residues 3, 12, 13, 14, 28, 29, 30, 31, 
33, 34, 35, 36, 44, 45, and 48. 
The dynamical properties of the PAFC were studied and compared with other an-
timicrobial MPs, such as PAF, NFAP, and PAFB, possessing β-barrel structures [10,19,30]. 
According to this study, the folded PAFC is mostly rigid; however, the N-terminal is 
more dynamical, and the C-terminal part of the first loop combined with the β2-strand 
and the long loop between the two β-sheets show some internal motion. Surprisingly, the 
second and third regions totally overlap the two γ-core motifs identified in PAFC. Alt-
hough the antifungal MPs of the PAF-clade also contain one γ-core motif, these proteins 
do not exhibit extreme dynamic regions [10,19,30]. Interestingly, cavity B in PAFC in-
volves the most dynamic part of the first γ-core region. So the flexible regions found in 
both γ-core regions of PAFC might have a potential role for ligand binding, allowing the 
conformational selection mode [49] for target molecule recognition. 
The evolutionary conserved γ-core motif, which is present in two levomeric forms 
in PAFC, is an important structural and/or functional component found in disul-
fide-stabilized proteins and peptides from organisms belonging to all kingdoms [22,23]. 
In MPs of filamentous ascomycetes, this motif localizes in conserved positions, being 
negatively charged, positively charged, or neutral [21]. Interestingly, the three members 
of the BP-clade (BP, PAFC, and PeAfpC) contain two levomeric motifs, the one in the 
central position being neutral or slightly negatively charged and a more positively 
charged one at the C-terminus [21]. It is the first time that the impact of the γ-core motif 
of BP-clade MPs on their function was investigated using synthetic peptides that span 
these regions. While the γ-core was shown to significantly contribute to the antifungal 
activity of PAF [21], this role could not be assigned yet to the respective motives in PAFC. 
Neither PCγ15 nor PCγC-terminal showed any efficacy against the growth of N. crassa and C. 
albicans. Instead, only the N-terminally extended PCγ17 having a higher positive net 
charge and being more hydrophilic exhibited a detectable IC90 against the filamentous 
model fungus but not against the yeast cells. This indicates that physicochemical features 
such as a positive net charge and hydrophilicity of the synthetic peptide play an im-
portant role in its species-specific function, but not the motif as such, and structural and 
functional support from other parts of the protein is required for full MP activity. This is 
consistent with studies performed with synthetic peptides comprising the dextromeric 
γ-core motif of the N. fischeri antifungal protein NFAP2 [44] and the P. digitatum anti-
fungal protein AfpB [42], which had no fungal growth inhibitory activity. 
By addressing the functional features in more detail, we provide evidence that 
PAFC exclusively inhibits the growth of filamentous fungi, as no antibacterial activity 
could be detected. These results complement the reported anti-Candida efficacy of PAFC 
[14], the anti-yeast activity of the P. brevicompactum BP [24], and the fungal growth in-
hibitory activity of Pc-Arctin from the artic sediment isolate P. chrysogenum A096, which 
is identical to PAFC [50]. Interestingly, PAFC was moderately active against its producer 
P. chrysogenum. Self-inhibition by the production of MPs has been reported previously for 
filamentous fungi, e.g., P. chrysogenum by PAFB [10], Penicillium digitatum by PdAfpB 
[51], or P. expansum by PeAfpA and PeAfpB [25]. Though still controversial, this obser-
vation could be explained with an additional function of the MPs, apart from their 
growth inhibitory activity, such as autophagy, nutrient recycling, and regulation of 
growth and development [10,14,52,53]. 
Furthermore, we investigated in this study the potential of PAFC as a bio-fungicide. 
It is the first time that the efficacy of a member of the BP-clade to protect tomato plant 
leaves from fungal infection was evaluated. The gray mold B. cinerea is a necrotrophic 
plant pathogen with the ability to infect numerous plant species, causing an estimated 
annual economic damage of one billion euros [54,55]. One of the hosts is the tomato plant 
(Solanum lysopersicum), an important and widely used agricultural crop. So far, infection 
control was managed by chemical fungicides [56], which, in itself, proves to be a problem 
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due to residues in tomato fruits and the risk of toxicity for consumers [57,58]. Addition-
ally, recent evidence showed that B. cinerea has already acquired resistance to many of the 
commonly used fungicides [59]. Apart from the effective reduction of tomato plant leaf 
destruction by mold-induced necrosis in the presence of PAFC, we also proved the tol-
erance of tomato leaves and M. truncatula seedlings to PAFC treatment. In-depth studies 
are currently in progress to further investigate the applicability of PAFC in agricultural 
and post-harvest settings to prevent and treat fungal plant infection and fruit decay. 
Taken together, the antifungal spectrum, which includes human as well as plant 
pathogens, suggests PAFC to be a potential candidate for the development of new anti-
fungal strategies applicable in the clinics and agriculture. 
4. Materials and Methods 
4.1. Microbial Strains and Growth Conditions 
Fungal and bacterial strains used in this study are listed in Supplementary Table S3, 
and the composition of the media is described in Supplementary Table S4. Spores were 
generated by cultivating P. chrysogenum on P. chrysogenum minimal medium (PcMM) 
agar plates at 25 °C and A. fumigatus, A. nidulans, and A. niger on solid complete medium 
(CM) at 37 °C. N. crassa was grown on Vogel’s agar plates at 37 °C under light. The der-
matophytes M. gypseum and T. rubrum were cultivated on oatmeal agar at 30 °C. B. cinerea 
was cultivated on potato dextrose agar (PDA; Sigma-Aldrich, St. Louis, MO, USA) and 
incubated first at 30 °C for 48 h and then at 25 °C for 10 days. All fungal spores were 
routinely harvested and washed in spore buffer (0.9% NaCl (w/v), 0.01% Tween (v/v)) 
before use, except for the spores of dermatophytes, which were harvested in spore buffer 
and filtered through a funnel lined with cotton to remove hyphae before washing the 
spores. A single colony of C. albicans was removed from PDA, transferred to liquid 0.1 × 
PDB, and grown at 160 rpm and 30 °C. After centrifugation, the cells were washed in the 
same medium before experimental use. E. coli and B. subtilis were grown as a preculture 
in lysogeny broth (LB) medium until an OD600nm of 0.3 was reached. 
4.2. PAFC Production 
We inoculated 200 mL of PcMM with 2  108 mL−1 spores of the 
PAFC-overexpressing strain P. chrysogenumOepafC [14], and PAFC was purified from the 
cell-free supernatant of a 96-h-old shaking culture (25 °C, 200 rpm), as previously de-
scribed [14]. Isotopic 15N/13C labeling of recombinant PAFC for NMR analysis was 
achieved by replacing the carbon and nitrogen source in PcMM with 1% 13C-glucose 
(w/v) (Euriso-Top, Saarbrücken, Germany) and 0.3% Na15NO3 (w/v) (Euriso-Top, Saar-
brücken, Germany), respectively. The isotopic-labeled PAFC was produced and purified 
in the same way as the unlabeled MP.  
4.3. NMR Measurements, Signal Assignment, and Structure Calculations  
Lyophilized PAFC samples were dissolved in 20 mM acetate buffer (pH = 4.5, 5% 
D2O) in a concentration of 650 μM. For NMR signal assignments, the standard protocol 
applied for other 15N-/13C-isotope-labeled antifungal MPs [60,61] was used. Thus, 
HNCO-, HN(CA)CO-, HNCA-, HN(CO)CA-, HNCACB-, HNHA-, HBHA(CO)NH-, and 
HN(CO)CACB-type three-dimensional triple-resonance experiments were recorded to 
identify sequential connections through the protein backbone. The side-chain resonance 
assignments were completed with the help of HC(C)H COSY, HC(C)H-TOCSY, 
HCC(CO)NH, and (H)CCH-TOCSY experiments. In the case of aromatic protons, 
two-dimensional CB(CGCD)HD and CB(CGCDCE)HE spectra were used. For NOE peak 
assignment and structure calculation, 15N- and 13C-resolved three-dimensional NOESY as 
well as 2D 1H-1H NOESY spectra were acquired. The identification of H-bonds was ac-
complished using the HNCOGPHB3D Bruker pulse sequence experiment [34]. All spec-
tra were recorded at 298 K using a Bruker NEO/Avance III 700 MHz spectrometer 
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(Bruker, Billerica, MA, USA). Typical 90° pulses were 8.1, 12, and 32 μs for 1H, 13C, and 
15N, respectively, and relaxation delays were in the 1.1–1.7 s range. Direct chemical shift 
referencing was performed for 1H using 2,2-dimethyl-2-sila-pentane-5-sulfonic acid 
(DSS), (Sigma-Aldrich, St. Louis, MO, USA) and an indirect one for 15N and 13C nuclei 
calculated from the gyromagnetic ratios. The spectra were processed using Topspin 3.1, 
and the resonances were identified and analyzed with CCPNmr Analysis 2.4.2 software 
[62]. For collecting backbone torsional angle restraints, the TALOS-N webserver was 
chosen [63,64]. The disulfide pattern was considered the same as in the case of BP, and 
these bonds were defined as covalent bond restraints for the structure calculation. NOE 
peak picking and assignment as well as the structure determination of PAFC were ac-
complished with the UNIO’10 platform [65,66], which is based on the ATNOS/CANDID 
algorithm and CYANA 2.1 software. For determining the initial protein fold, only NOE 
distance constraints were considered. The refinement of the three-dimensional structure 
was completed with disulfide bond pattern and backbone torsional angle restraints [64]. 
In the final structure calculation, 1421 NOEs were included in the optimization. As usual, 
100 conformers were determined, and the 20 lowest-energy structures of them were se-
lected to obtain the final structural ensemble. For the dynamical studies of PAFC, con-
ventional 15N (70.966 MHz), relaxation experiments (T1, T2, and 15N-1H NOE) were also 
run on the Bruker NEO/Avance III 700 MHz spectrometer using the 15N-/13C-labeled 
PAFC sample at 298 K. 15N-{1H} NOEs were measured using Bruker’s hsqcnoef3gpsi 
pulse program. The recycle delay was 7 s in the reference experiment, and the same du-
ration was applied for the pre-saturation 1H pulse train, which was a train of 120° proton 
pulses (10.8 μs), followed by 5 ms delays in the on-resonance experiment. 15N T1 and T2 
relaxation times were measured using standard pulse sequences hsqct1etgpsi3d.2 and 
hsqct2etgpsi3d.2, with 3 s recycle delays. The 15N relaxation data were analyzed using 
the Lipari–Szabo method of Bruker Dynamics Center version 2.4.8 software (Bruker, 
Billerica, MA, USA). The global correlation time and the S2 order parameters for each aa 
residue were calculated applying the M2 model, which includes residue-specific order 
parameters and effective correlation times and one global correlation time of an isotropic 
rotor. To obtain more insight into the dynamical properties of PAFC, the same relaxation 
data were analyzed with the aid of reduced spectral density mapping [40] using 
in-house-written MATLAB code. CPMG-RD experiments [67,68] were recorded to dis-
close possible motions at the millisecond timescale. 15N CPMG-RD T2 relaxation disper-
sion experiments were carried out as a function of the applied B1 RF field. Bruker’s 
hsqcrexetf3gpsi3d pulse program was applied. The B1 field was changed in between the 
0–1000 Hz range, in 13 steps. The recycle delay was 2 s. 
4.4. ECD Spectroscopy 
The secondary structure and thermal stability of PAFC were assessed using ECD 
spectroscopy. Spectra were recorded in the 195–260 nm wavelength range at a scan speed 
of 100 nm s−1 using a Jasco-J815 spectropolarimeter (JASCO Corporation, Tokyo, Japan). 
The protein sample was dissolved in H2O at a 0.1 mg mL−1 concentration and transferred 
to a 0.1-cm-path-length quartz cuvette for the following measurements. First, the ECD 
spectrum of the sample was recorded at 25 °C. The temperature was then gradually in-
creased up to 95 °C at a rate of 1 °C min−1 using a Peltier thermo-electronic controller (TE 
Technology, Traverse City, MI, USA), while ellipticity data were recorded as a function of 
temperature at four wavelengths (195, 202, 215, and 229 nm) appointed by the extrema of 
the spectrum measured at 25 °C and characteristic wavelengths determined previously 
for related proteins [41–44]. The protein solution was equilibrated for 1 min at each 
temperature point before measurements were taken. The resultant melting curves were 
fitted with a symmetrical sigmoidal function whose inflexion points corresponded to the 
melting temperature (Tm) of the protein structure. When the unfolding experiment 
reached its final temperature point at 95 °C, the ECD spectrum in the 195–260 nm range 
was recorded again, and then the sample was left to cool to 25 °C. The last spectrum ac-
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quisition was done at 25 °C, after 5 min equilibration. The reported spectra were accu-
mulations of 10 scans, from which the spectrum of H2O was subtracted. Ellipticity data 
are given in mdeg units. 
Contributions of spectral signatures to the ECD spectra, emerging from different 
secondary structural regions of the protein, were determined by the circular dichroism 
spectra secondary structure (CDSSTR) method [69]. Deconvolution data were then 
compared to values reported by DSSP analysis [36] of the NMR-derived structure re-
ported here and the crystallographic structure of the homologous P. brevicompactum BP 
(pdb code 1UOY). 
4.5. Synthesis of γ-Core Peptides PCγ15, PCγ17, and PCγC-terminal 
The peptides were prepared manually by solid-phase peptide synthesis, applying 
Fmoc chemistry and dicyclohexylcarbodiimide/N-hydroxybenzotriazole (DCC/HOBt) 
coupling with a three-fold excess of reagents. Rink amide resin was used as a solid sup-
port. As the last step of the synthesis, the N-terminal amino group of the peptide was 
acetylated on the solid phase. The peptide was cleaved simultaneously from the resin 
and the side chains deprotected with a 95:5:3 (v/v/w) trifluoroacetic acid (TFA) 
/water/dithiothreitol mixture at room temperature for 2.5 h. The crude peptide was puri-
fied by semi-preparative reversed-phase high-performance liquid chromatography 
(RP-HPLC) on a Phenomenex Luna 10 μm C18 column using the following eluent sys-
tem: (A) 0.1% (v/v) TFA and (B) 80% (v/v) acetonitrile and 0.1% (v/v) TFA applying a lin-
ear gradient from 10% to 40% B (PCγ15 and PCγ17) or 0% to 30% B (PCγC-terminal) in 60 
min at a flow rate of 3.0 mL min−1. Purity was checked with a Phenomenex Luna 10 μm 
C18 100 Å column and a linear gradient from 28% to 43% B (PCγ15), from 22% to 37% B 
(PCγ17), or from 8% to 23% B (PCγC-terminal) in 15 min (Supplementary Figure S6). The 
identity of the peptide was proven by electrospray ionization–mass spectrometry 
(ESI-MS). 
4.6. Determination of Antimicrobial Activity  
The inhibitory concentration that reduces microbial growth by ≥90% (IC90) was de-
termined using broth microdilution assays. To this end, 100 μL of fungal spores or yeast 
cells (104 mL−1) were mixed with 100 μL of PAFC in 0.1 × PDB in increasing concentra-
tions (dermatophytes: 0–20 μM; Aspergillus spp., N. crassa: 0–30 μM; P. chysogenum: 0–100 
μM; Candida: 0–20 μM) in 96-well, flat-bottom microtiter plates (Thermo Scientific, Wal-
tham, MA, USA). E. coli and B. subtilis precultures were grown in 0.1 × PDB until an 
OD620nm of 0.3 was reached, and diluted to an OD620nm of 0.1 and mixed with 100 μL of 
increasing PAFC concentrations (0–50 μM). The growth inhibition of the static cultures 
was evaluated by determining the optical density (OD620nm) with a multi-mode micro-
plate reader (FLUOstar Omega, BMG Labtech, Ortenberg, Germany) after cultivation of 
Aspergillus spp. and C. albicans for 24 h at 30 °C. N. crassa was incubated for 16–30 h at 25 
°C, and dermatophytes were cultivated for eight days at 30 °C. Bacterial growth was 
evaluated after 24 h of cultivation at 30 °C. All assays included a blank (culture broth 
without spores or cells) for background subtraction and respective untreated microor-
ganisms, which served as a growth control representing 100% growth. All experiments 
were done in technical triplicates and repeated at least twice. Agar diffusion assays were 
performed to document the degree of hyphal extension inhibition by PAFC in B. cinerea 
surface culture. Solid culture medium (0.1 × PDA) was overlaid with 1 mL of 2 × 105 co-
nidia mL−1, and 100 μL of 0.25–1 mg mL–1 PAFC solution diluted in sterile ddH2O was 
filled into the wells, which had been punched into the solid medium. Sterile ddH2O was 
used as a negative inhibition control. The diameters of the inhibition zones that had 
formed around the wells were documented after incubation for 96 h at 25 °C. The ex-
periment was repeated twice. 
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4.7. Toxicity Tests with Medicaco truncatula Seedlings 
To exclude any potential toxic effects of PAFC during plant growth, an experiment 
with the plant seeds of M. truncatula A-17 was conducted [13]. In short, seeds were steri-
lized, placed on 1% (w/v) water agar (Kalys, Bernin, France), and germinated at 4 °C in 
the dark for three days. Seedlings with 3–4 mm root length were chosen for the experi-
ment, and four seedlings per square Petri dish with vents (Greiner, Sigma-Aldrich, St. 
Louis, MO, USA) containing water agar were put next to each other, keeping a 20 mm 
distance from the top. The apical region of the primary root was treated for 10 days with 
daily doses of an aqueous 20 μL PAFC solution (1 mg mL−1) and incubated in a 60% hu-
mid plant growth chamber at 23 °C and 1200 lux illumination for the leaf region, while 
evolving roots were kept in the dark by covering the respective region of the dish with 
aluminum foil. The primary root length was measured in millimeters and the number of 
lateral roots counted at day 10 of incubation. Seedlings treated with ddH2O and 70% (v/v) 
ethanol were used as growth and death controls, respectively. The toxicity test was re-
peated at least twice. 
4.8. Plant Protection Experiments 
Tomato plant seeds (Solanum lycopersicum L. cv. Ailsa Craig) were germinated for 
three days at 27 °C under darkness, and then the seedlings were transferred to Perlite for 
14 days and grown in a controlled environment (200 μmol m−2 s−1 photon flux density 
with 12/12 h light/dark period, a day/night temperature of 23 °C/20 °C, and a relative 
humidity of 55%–60% for 4 weeks) in hydroponic culture [70]. The plant protection ex-
periments were conducted from 9:00 a.m. For the assessment of PAFC efficacy to protect 
against fungal infection, the pathogenicity test method described by [71,72] was adopted 
with slight modifications. Detached tomato plant leaves were positioned in Petri dishes 
containing three sterilized filter papers (Filters Fioroni, Ingré, France) wetted with sterile 
ddH2O. (i) For infection control, 10 μL of B. cinerea SZMC 21,472 conidial suspension (1 × 
107 conidia mL−1), (ii) for PAFC toxicity testing, 10 μL of 1 mg mL−1 PAFC, (iii) for plant 
protection investigation, 10 μL of B. cinerea conidial suspension (1 × 107 conidia mL−1) 
containing PAFC in a concentration range of 0.25–1 μg mL−1, and (iv) for the un-infected 
control, 10 μL of 0.1 × PDB was dropped onto the abaxial leaf epidermis at three points 
between the later veins and left to dry on the surface at room temperature. Conidial 
suspensions and PAFC solutions were prepared in 0.1 × PDB for the tests. After these 
treatments, leaves were kept in a humid (60%) plant growth chamber for four days at 23 
°C under photoperiodic day/night simulation (12/12 h with/without illumination at 1200 
lux). Leaves left untreated were used as untreated controls. After the incubation period, 
the leaves were collected and the necrotic zone around the treatment points and the ne-
crotic lesions were visualized by Evan’s blue staining. Briefly, the leaves were stained 
with 1% (w/v) Evan’s blue (Sigma-Aldrich, St Louis, MO, USA) for 10 min according to 
[73] and then rinsed with distilled water until they were fully decolorized. Then the 
chlorophyll content was eliminated by boiling in 96% (v/v) ethanol for 15 min. The leaves 
were stored in a glycerine:water:alcohol (4:4:2) solution and photographed with a Canon 
EOS 700D camera (Tokyo, Japan). Three leaves for each treatment were used in one ex-
periment. The plant protection experiment was repeated twice. 
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BP Penicillium brevicompactum bubble protein 
BMRB Biological magnetic resonance data bank 
CDSSTR Circular dichroism spectra secondary structure 
CPMG-RD  Carr–Purcell–Meiboom–Gill relaxation dispersion 
DSSP Dictionary secondary structures of protein 
DI Disorder index 
ECD Electronic circular dichroism 
fASA Fractional associated solvent area 
GRAVY Grand average of hydropathy value 
HI-HSQC Heteronuclear in-phase single quantum coherence 
IC90 Inhibitory concentration reducing microbial growth by ≥90% 
kDa kiloDalton 
K Kelvin 
MP(s) Miniprotein(s) 
NFAP Neosartorya fischeri antifungal protein 
NMR  Nuclear magnetic resonance 
NOE Nuclear Overhauser effect 
OD Optical density 
PAF  Penicillium chrysogenum antifungal protein  
PdAfp Penicillium digitatum antifungal protein  
PeAfp Penicillium expansum antifungal protein 
pdb Protein Data Bank 
RCI Random coil index 
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